Literature DB >> 23539190

Cost effectiveness of guanfacine extended-release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder: application of a matching-adjusted indirect comparison.

Carlos I Alatorre, Virginia Haynes, Douglas Faries, Himanshu Upadhyaya, Douglas Kelsey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23539190     DOI: 10.1007/s40258-013-0024-2

Source DB:  PubMed          Journal:  Appl Health Econ Health Policy        ISSN: 1175-5652            Impact factor:   2.561


× No keyword cloud information.
  1 in total

1.  Authors' reply to Alatorre et al.: "cost effectiveness of guanfacine extended-release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder: application of a matching-adjusted indirect comparison".

Authors:  M Haim Erder; Jipan Xie; James E Signorovitch; Kristina S Chen; Paul Hodgkins; Mei Lu; Eric Q Wu; Vanja Sikirica
Journal:  Appl Health Econ Health Policy       Date:  2013-06       Impact factor: 2.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.